Current Funding Need: $3 million

• Goal 5: Clinical Trial

  • $3 million to start treating Frizzle patients in a clinical trial and to conduct an US FDA required natural history study.

  • Our hope is to begin a clinical trial by fall 2026.

    Note: Our projected timeline for fundraising and treatment development is completely dependent on funds being raised to pay for each stage. We hope to raise the funds needed as soon as possible to keep the treatment development process moving; however, it is subject to change.